Growth and Puberty in Children with Inflammatory Bowel Diseases
暂无分享,去创建一个
[1] T. Pizarro,et al. Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease , 2020, Nature Reviews Gastroenterology & Hepatology.
[2] L. Peyrin-Biroulet,et al. Targeting the gut layers in Crohn’s disease: mucosal or transmural healing? , 2020, Expert review of gastroenterology & hepatology.
[3] B. Koletzko,et al. Partial enteral nutrition has no benefit on bone health but improves growth in paediatric patients with quiescent or mild Crohn's disease. , 2020, Clinical nutrition.
[4] N. Gupta,et al. Introduction to and Screening Visit Results of the Multicenter Pediatric Crohn's Disease Growth Study. , 2020, Inflammatory bowel diseases.
[5] M. Neovius,et al. Adult height in patients with childhood‐onset inflammatory bowel disease: a nationwide population‐based cohort study , 2020, Alimentary pharmacology & therapeutics.
[6] B. Ranchin,et al. Efficacy and safety of recombinant growth hormone treatment in children with growth retardation related to long-term glucocorticosteroid therapy. , 2019, Annales d'endocrinologie.
[7] G. A. P. Silva,et al. Linear growth and bone metabolism in pediatric patients with inflammatory bowel disease. , 2019, Jornal de pediatria.
[8] T. Ishige. Growth failure in pediatric onset inflammatory bowel disease: mechanisms, epidemiology, and management. , 2019, Translational pediatrics.
[9] R. Shamir,et al. Anthropometric Measures in Adolescents With Inflammatory Bowel Disease: A Population-Based Study. , 2018, Inflammatory bowel diseases.
[10] J. D. del Campo,et al. Modulation of faecal metagenome in Crohn’s disease: Role of microRNAs as biomarkers , 2018, World journal of gastroenterology.
[11] J. Doré,et al. Mucosal healing and bacterial composition in response to enteral nutrition versus steroid based induction therapy - a randomized prospective clinical trial in children with Crohn's disease. , 2018, Journal of Crohn's & colitis.
[12] Y. Naito,et al. Gut microbiota in the pathogenesis of inflammatory bowel disease , 2018, Clinical Journal of Gastroenterology.
[13] C. Croce,et al. MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers — their effects and therapeutic potentials , 2017, Current opinion in pharmacology.
[14] David V. Evans,et al. An Update on Inflammatory Bowel Disease. , 2017, Primary care.
[15] M. Neovius,et al. Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014 , 2017, British Medical Journal.
[16] I. Monteiro,et al. Diagnosis and management of inflammatory bowel disease in children , 2017, British Medical Journal.
[17] J. Kopchick,et al. Growth Hormone Resistance—Special Focus on Inflammatory Bowel Disease , 2017, International journal of molecular sciences.
[18] D. Tanyingoh,et al. Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases , 2017, The American Journal of Gastroenterology.
[19] Liu Hong,et al. Role of MiRNAs in Inflammatory Bowel Disease , 2017, Digestive Diseases and Sciences.
[20] M. Eisenhut,et al. IBD immunopathogenesis: A comprehensive review of inflammatory molecules. , 2017, Autoimmunity reviews.
[21] R. Russell,et al. Disease Status and Pubertal Stage Predict Improved Growth in Antitumor Necrosis Factor Therapy for Pediatric Inflammatory Bowel Disease , 2017, Journal of pediatric gastroenterology and nutrition.
[22] M. Kawahara,et al. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease , 2017, Journal of Gastroenterology.
[23] C. Farquharson,et al. Growth and the Growth Hormone-Insulin Like Growth Factor 1 Axis in Children With Chronic Inflammation: Current Evidence, Gaps in Knowledge, and Future Directions. , 2016, Endocrine reviews.
[24] H. Herfarth,et al. Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases , 2016, Inflammatory bowel diseases.
[25] S. Saeed,et al. Inflammatory Bowel Disease in Children and Adolescents. , 2021, Advances in pediatrics.
[26] G. Rogler,et al. Extraintestinal Manifestations of Inflammatory Bowel Disease , 2015, Inflammatory bowel diseases.
[27] Christoph Beglinger,et al. The role and utility of faecal markers in inflammatory bowel disease , 2015, Therapeutic advances in gastroenterology.
[28] E. Semikina,et al. Cytokine profile in children with inflammatory bowel disease , 2014, Biochemistry (Moscow).
[29] C. Braegger,et al. Early-onset Crohn’s disease is a risk factor for smaller final height , 2014, European journal of gastroenterology & hepatology.
[30] G. Guariso,et al. Crohn's disease and growth deficiency in children and adolescents. , 2014, World journal of gastroenterology.
[31] A. Griffiths,et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. , 2014, Journal of Crohn's & colitis.
[32] V. Locatelli,et al. Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis , 2014, International journal of endocrinology.
[33] I. Sanderson. Growth problems in children with IBD , 2014, Nature Reviews Gastroenterology &Hepatology.
[34] Carl A. Anderson,et al. Genetic studies of Crohn's disease: Past, present and future , 2014, Best practice & research. Clinical gastroenterology.
[35] O. Mäkitie,et al. Compromised peak bone mass in patients with inflammatory bowel disease--a prospective study. , 2014, The Journal of pediatrics.
[36] R. Hill. Update on nutritional status, body composition and growth in paediatric inflammatory bowel disease. , 2014, World journal of gastroenterology.
[37] A. Ananthakrishnan,et al. Review article: vitamin D and inflammatory bowel diseases , 2014, Alimentary pharmacology & therapeutics.
[38] D. Iliopoulos,et al. MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. , 2013, Gastroenterology.
[39] L. Denson,et al. Delays in puberty, growth, and accrual of bone mineral density in pediatric Crohn's disease: despite temporal changes in disease severity, the need for monitoring remains. , 2013, The Journal of pediatrics.
[40] M. Collet,et al. Puberté, fertilité et maladies chroniques , 2013 .
[41] A. Besançon,et al. [Puberty, fertility and chronic diseases]. , 2013, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
[42] V. Marchand. The toddler who is falling off the growth chart. , 2012, Paediatrics & child health.
[43] C. Elias,et al. Leptin signaling and circuits in puberty and fertility , 2012, Cellular and Molecular Life Sciences.
[44] H. El‐Serag,et al. Natural History of Pediatric-onset Inflammatory Bowel Disease: A Systematic Review , 2012, Journal of clinical gastroenterology.
[45] A. Griffiths,et al. Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children. , 2012, Gastroenterology.
[46] P. Marques‐Vidal,et al. Impact of Disease and Treatments on Growth and Puberty of Pediatric Patients with Inflammatory Bowel Disease , 2012, Digestion.
[47] A. Akobeng,et al. The effects of anti-TNF-α treatment with adalimumab on growth in children with Crohn's disease (CD). , 2012, Journal of Crohn's & colitis.
[48] A. Griffiths,et al. Induction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitis. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[49] P. Adamski,et al. Horizontal Distribution of the Fecal Microbiota in Adolescents With Inflammatory Bowel Disease , 2012, Journal of pediatric gastroenterology and nutrition.
[50] E. Vittinghoff,et al. Sex differences in statural growth impairment in Crohn's disease: Role of IGF‐1 , 2011, Inflammatory bowel diseases.
[51] Beppie van den Bogaerde,et al. Clinical practice , 2011, European Journal of Pediatrics.
[52] V. de Lédinghen,et al. Mucosal healing with methotrexate in Crohn’s disease: a prospective comparative study with azathioprine and infliximab , 2011, Alimentary pharmacology & therapeutics.
[53] P. Rzehak,et al. Childhood onset inflammatory bowel disease: predictors of delayed diagnosis from the CEDATA German-language pediatric inflammatory bowel disease registry. , 2011, The Journal of pediatrics.
[54] R. Russell,et al. Improvement in Growth of Children With Crohn Disease Following Anti-TNF-α Therapy Can Be Independent of Pubertal Progress and Glucocorticoid Reduction , 2011, Journal of pediatric gastroenterology and nutrition.
[55] M. DeBoer,et al. Puberty Is Delayed in Male Mice With Dextran Sodium Sulfate Colitis Out of Proportion to Changes in Food Intake, Body Weight, and Serum Levels of Leptin , 2011, Pediatric Research.
[56] J. Hirschhorn,et al. Association of Linear Growth Impairment in Pediatric Crohn's Disease and a Known Height Locus: A Pilot Study , 2010, Annals of human genetics.
[57] C. O'Morain,et al. Therapeutic benefits of budesonide in gastroenterology , 2010, Therapeutic advances in chronic disease.
[58] M. Oliva-Hemker,et al. Nutritional considerations in pediatric inflammatory bowel disease , 2010, Expert review of gastroenterology & hepatology.
[59] A. Day,et al. Infliximab improves inflammation and anthropometric measures in pediatric Crohn's disease , 2010, Journal of gastroenterology and hepatology.
[60] W. Fraser,et al. IL-6 May Modulate the Skeletal Response to Glucocorticoids During Exacerbations of Inflammatory Bowel Disease , 2010, Calcified Tissue International.
[61] S. Kugathasan,et al. Pediatric inflammatory bowel disease: highlighting pediatric differences in IBD. , 2009, Gastroenterology clinics of North America.
[62] S. Cohn,et al. Colitis causes delay in puberty in female mice out of proportion to changes in leptin and corticosterone , 2010, Journal of Gastroenterology.
[63] A. Griffiths,et al. Long‐term outcome of maintenance infliximab therapy in children with Crohn's disease , 2009, Inflammatory bowel diseases.
[64] R. Shamir. Nutritional Aspects in Inflammatory Bowel Disease , 2009, Journal of pediatric gastroenterology and nutrition.
[65] J. Sarles,et al. Efficacy of Infliximab in Pediatric Crohn's Disease: A Randomized Multicenter Open‐Label Trial Comparing Scheduled to On Demand Maintenance Therapy , 2009, Inflammatory bowel diseases.
[66] T. Raivio,et al. Bone turnover and metabolism in paediatric patients with inflammatory bowel disease treated with systemic glucocorticoids. , 2008, European journal of endocrinology.
[67] S. Brant,et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. , 2008, Gastroenterology.
[68] A. Griffiths,et al. Guidelines for the management of growth failure in childhood inflammatory bowel disease. , 2008, Inflammatory bowel diseases.
[69] T. Raivio,et al. P147 Bone Turnover in Paediatric Patients with Inflammatory Bowel Disease Treated with Systemic Glucocorticoids , 2008 .
[70] M. Castro,et al. Positive impact of blocking tumor necrosis factor α on the nutritional status in pediatric Crohn’s disease patients , 2008, International Journal of Colorectal Disease.
[71] R. Baldassano,et al. Gender Differences in Presentation and Course of Disease in Pediatric Patients With Crohn Disease , 2007, Pediatrics.
[72] N. Afzal,et al. Infliximab Delays but Does Not Avoid the Need for Surgery in Treatment-Resistant Pediatric Crohn’ Disease , 2007, Digestive Diseases and Sciences.
[73] M. Phillip,et al. Growth retardation in pediatric Crohn's disease: Pathogenesis and interventions , 2007, Inflammatory bowel diseases.
[74] Athos Bousvaros,et al. The Crohn’s and Colitis Foundation of America , 2018, The Grants Register 2019.
[75] A. Griffiths,et al. Linear Growth Improves during Infliximab Therapy in Children with Chronically Active Severe Crohn's Disease , 2007, Inflammatory bowel diseases.
[76] A. Griffiths,et al. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. , 2007, Gastroenterology.
[77] S. Ahmed,et al. The Effects of Recombinant Human Growth Hormone on Linear Growth in Children with Crohn's Disease and Short Stature , 2007, Journal of pediatric endocrinology & metabolism : JPEM.
[78] V. Macrae,et al. The Role of Pro-Inflammatory Cytokines in Inflammatory Bowel Disease Growth Retardation , 2006, Journal of pediatric gastroenterology and nutrition.
[79] M. Savage,et al. Clinical Features Affecting Final Adult Height in Patients With Pediatric-Onset Crohn's Disease , 2006, Pediatrics.
[80] S. Uccini,et al. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[81] Devinder Kumar,et al. Surgery results in significant improvement in growth in children with Crohn’s disease refractory to medical therapy , 2006, Pediatric Surgery International.
[82] P. Rutgeerts,et al. Laboratory markers in IBD: useful, magic, or unnecessary toys? , 2006, Gut.
[83] H. Drummond,et al. Edinburgh Research Explorer Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease , 2022 .
[84] R. Balicer,et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease , 2005, Gut.
[85] J. Auwerx,et al. Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator–activated receptor-γ , 2005, The Journal of experimental medicine.
[86] D. Felsenberg,et al. Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[87] M. Savage,et al. IGFs and IGFBPs in GH insensitivity. , 2005, Endocrine development.
[88] E. Leshinsky‐Silver,et al. Pediatric Crohn's Disease and Growth Retardation: The Role of Genotype, Phenotype, and Disease Severity , 2004, Pediatrics.
[89] M. Kiely,et al. Vitamin K Status in Patients with Crohn's Disease and Relationship to Bone Turnover , 2004, The American Journal of Gastroenterology.
[90] S. Abrams,et al. Zinc Metabolism in Adolescents with Crohn's Disease , 2004, Pediatric Research.
[91] A. Griffiths. Specificities of inflammatory bowel disease in childhood. , 2004, Best practice & research. Clinical gastroenterology.
[92] Keesook Lee,et al. Molecular Mechanism of Suppression of Testicular Steroidogenesis by Proinflammatory Cytokine Tumor Necrosis Factor Alpha , 2004, Molecular and Cellular Biology.
[93] L. Bodin,et al. Elemental versus polymeric enteral nutrition in paediatric Crohn's disease: a multicentre randomized controlled trial , 2004 .
[94] M. Savage,et al. Anti-Inflammatory and Growth-Stimulating Effects Precede Nutritional Restitution During Enteral Feeding in Crohn Disease , 2004, Journal of pediatric gastroenterology and nutrition.
[95] B. Sandhu,et al. Presenting features of inflammatory bowel disease in Great Britain and Ireland , 2003, Archives of disease in childhood.
[96] H. Bettiol,et al. Acompanhamento do crescimento , 2003 .
[97] S. Murch,et al. High‐dose azathioprine in children with inflammatory bowel disease , 2003, Alimentary pharmacology & therapeutics.
[98] M. Savage,et al. Delayed Puberty Associated with Inflammatory Bowel Disease , 2003, Pediatric Research.
[99] R. Baldassano,et al. Lamina propria and circulating interleukin-6 in newly diagnosed pediatric inflammatory bowel disease patients , 2002, American Journal of Gastroenterology.
[100] M. Mearin,et al. Adult height in patients with early onset of Crohn's disease , 2002, Gut.
[101] S. Cucchiara,et al. Azathioprine in paediatric inflammatory bowel disease: an Italian multicentre survey , 2002, Alimentary pharmacology & therapeutics.
[102] S. Poole,et al. Anorexia in a rat model of colitis: interaction of interleukin-1 and hypothalamic serotonin , 2002, Brain Research.
[103] M. Adamo,et al. Dexamethasone decreases serum and liver IGF-I and maintains liver IGF-I mRNA in parenterally fed rats. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.
[104] P. Clayton,et al. Low Serum Concentrations of Insulin-like Growth Factor-I in Children with Active Crohn Disease: Effect of Enteral Nutritional Support and Glutamine Supplementation , 2002, Scandinavian journal of gastroenterology.
[105] J. Markowitz,et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. , 2000, Gastroenterology.
[106] M. Farthing,et al. Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis , 2000, Gut.
[107] D. Perrett,et al. The role of medial hypothalamic serotonin in the suppression of feeding in a rat model of colitis. , 2000, Gastroenterology.
[108] Katsuki Ito,et al. Interleukin‐6 and soluble interleukin‐6 receptor in the colonic mucosa of inflammatory bowel disease , 1999, Journal of gastroenterology and hepatology.
[109] B. Kirschner,et al. Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease. , 1998, Gastroenterology.
[110] M. Savage,et al. Responsiveness of IGF‐I and IGFBP‐3 to therapeutic intervention in children and adolescents with Crohn's disease , 1998, Clinical endocrinology.
[111] A. Parfitt,et al. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. , 1998, The Journal of clinical investigation.
[112] C. Ohlsson,et al. Dexamethasone Impairs Growth Hormone (GH)-Stimulated Growth by Suppression of Local Insulin-Like Growth Factor (IGF)-I Production and Expression of GH- and IGF-I-Receptor in Cultured Rat Chondrocytes. , 1998, Endocrinology.
[113] DB Allen,et al. Influence of inhaled corticosteroids on growth: a pediatric endocrinologist's perspective , 1998, Acta paediatrica.
[114] C. Rubin,et al. Experimental colitis impairs linear bone growth independent of nutritional factors. , 1997, Journal of pediatric gastroenterology and nutrition.
[115] C. Mantzoros,et al. A Longitudinal Assessment of Hormonal and Physical Alterations during Normal Puberty in Boys. v. Rising Leptin Levels May Signal the Onset of Puberty* , 2022 .
[116] A. Rogol,et al. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. III. The neuroendocrine growth hormone axis during late prepuberty. , 1996, The Journal of clinical endocrinology and metabolism.
[117] D. Allen. Growth suppression by glucocorticoid therapy. , 1996, Endocrinology and metabolism clinics of North America.
[118] M. Corey,et al. Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. , 1996, Gut.
[119] H. Büller,et al. Mechanisms of Growth Retardation, Drug Therapy, and Nutritional Support in Pediatric Inflammatory Bowel Disease: A Workshop Sponsored by the North American and European Societies for Pediatric Gastroenterology and Nutrition , 1995, Inflammatory bowel diseases.
[120] W. Walker,et al. Profile of IGF-binding proteins secreted by intestinal epithelial cells changes with differentiation. , 1994, The American journal of physiology.
[121] A. Ferguson,et al. Juvenile onset inflammatory bowel disease: height and body mass index in adult life , 1994, BMJ.
[122] V. Fazio,et al. The Results of Strictureplasty in Pediatric Patients with Multifocal Crohn's Disease , 1994, Journal of pediatric gastroenterology and nutrition.
[123] C. Brain,et al. Growth and puberty in chronic inflammatory bowel disease. , 1994, Bailliere's clinical gastroenterology.
[124] E. Hunziker,et al. Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo. , 1994, The Journal of clinical investigation.
[125] J. Karlberg,et al. Longitudinal Growth in Children and Adolescents with Inflammatory Bowel Disease , 1994, Journal of pediatric gastroenterology and nutrition.
[126] N. Belova,et al. Blockade by interleukin-1-alpha of nitricoxidergic control of luteinizing hormone-releasing hormone release in vivo and in vitro. , 1994, Neuroimmunomodulation.
[127] J. Markowitz,et al. Growth failure in pediatric inflammatory bowel disease. , 1993, Journal of pediatric gastroenterology and nutrition.
[128] M. Savage,et al. Urinary Growth Hormone in Growth‐Impaired Children with Chronic Inflammatory Bowel Disease , 1993, Journal of pediatric gastroenterology and nutrition.
[129] A. Giustina,et al. The role of glucocorticoids in the regulation of growth hormone secretion Mechanisms and clinical significance , 1992, Trends in Endocrinology & Metabolism.
[130] R. Lange,et al. Gastric emptying in childhood inflammatory bowel disease: nutritional and pathologic correlates. , 1992, The American journal of gastroenterology.
[131] L. Dunkel,et al. Delayed puberty , 2018, Rapid Paediatrics and Child Health.
[132] C. Edwards,et al. Nocturnal growth hormone and gonadotrophin secretion in growth retarded children with Crohn's disease. , 1981, Gut.
[133] A. Tenore,et al. Basal and stimulated serum growth hormone concentrations in inflammatory bowel disease. , 1977, The Journal of clinical endocrinology and metabolism.